Pediatric Liver Transplantation Clinical Trial
Official title:
Incidence and Risk Factors of Prolonged Post-Operative Mechanical Ventilation in Pediatric Liver Transplant Recipients: A Retrospective Study
The primary goal of the study is to identify incidence and risk factors for PPMV in pediatric patients undergoing liver transplantation.
The vast majority of children undergoing orthotopic liver transplantation (OLT) are maintained on mechanical ventilation (MV) in the immediate postoperative period. Reasons for this practice include concerns about graft function, postoperative respiratory depression from opioids, preexisting malnutrition, and organ-recipient size mismatch as well as poor cooperation of young children with postoperative instructions. With current improvements in the perioperative care, there is increasing drive towards early extubation in both adults and children. Although many children require only a few days of MV following OLT, some require a more prolonged course. In general, prolonged postoperative mechanical ventilation (PPMV) in intensive care unit (ICU) patients is marker of severe adverse events and is associated with higher morbidity and mortality as well as extraordinary resource utilization. Patients requiring PPMV have survived the acute phase of surgery but spend an increased amount of time in the ICU, consume about 50% of all intensive care unit (ICU) resources and are more likely to die. Consequently, investigating the incidence and factors predisposing to PPMV following liver transplant is an important area of research with potential to reduce cost of care and improve long-term outcome of patients. To our knowledge, factors associated with PPMV following pediatric liver transplantation have not been comprehensively characterized. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04792788 -
NAVA vs PSV Ventilation During Weaning From Mechanical Ventilation in Children After Liver Transplantation
|
N/A | |
Recruiting |
NCT04518332 -
Intraoperative Cerebral and Renal Tissue Oxygen Saturation and Pediatric Living Donor Liver Transplantation Prognosis.
|
||
Terminated |
NCT02630563 -
Safety, Tolerability and Pharmacokinetics of Oral CellCept (Mycophenolate Mofetil) in Pediatric Liver Transplant Recipients on Concomitant Treatment With Cyclosporine and Corticosteroids
|
Phase 4 | |
Recruiting |
NCT02957552 -
Safety and Tolerance of Immunomodulating Therapy With Donor-specific MSC in Pediatric Living-Donor Liver Transplantation
|
Phase 1 | |
Recruiting |
NCT02064777 -
Prospective Tacrolimus Pharmacokinetics Study in Pediatric Living Donor Liver Transplantation
|
Phase 4 | |
Recruiting |
NCT03494595 -
Thromboelastometry as a Predictor of Thrombotic Complications During Pediatric Recipient Liver Transplantation
|